For the first time, the FDA has formally recognized the process that led to curation of a public database containing information about genes, gene variants (including PTEN) and their relationship to disease as a source of scientific evidence that can be used to support clinical validity in pre-market submissions.Read More
Thomas E. Fagan, MD, joined Cleveland Clinic Children’s as Director of Pediatric and Congenital Cardiac Catheterization Laboratory in 2018. He sat down with CQD to discuss the team’s approach to congenital heart disease.
Levels of circulating, donor-derived cfDNA act as a marker of rejection and can help distinguish antibody-mediated rejection from nonantibody-mediated rejection.
Our Sleep Disorders Center is using the funds to create a first-of-kind sleep biophysiologic repository leveraging over 100,000 sleep studies and to study links between sleep apnea and QT prolongation.
A genetic mutation found only in individuals of African descent confers higher risk of chronic kidney disease. It could also be key in reducing transplant rejection.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Patients will now have a single point of entry for evidence-based weight management.
Key points to share with your patients who arrive with consumer genetic testing report in hand, and when to refer them to specialists.
An endocrine surgeon explains when parathyroidectomy is indicated, how it’s performed and how it can help patients with hyperparathyroidism.
The personal mutanome is an innovative computational tool that models the DNA landscape of a patient’s genome, which may help clinicians to fulfill the promise of precision medicine.
Get up to speed on lead management and challenging clinical scenarios in electrophysiology with our two CME dinner programs at the year’s premier heart rhythm gathering.